Glaucoma Detection in UK Independent Optician Practices: Building a Detection and Referral Pathway That Actually Works in 2026

Glaucoma Detection in UK Independent Optician Practices: Building a Detection and Referral Pathway That Actually Works in 2026

Glaucoma is the kind of condition independent UK opticians sit on the front line of, whether they want to or not. Patients aren’t being referred to you to look for it — they’re walking in for a routine sight test, and you’re the first clinician who has the chance to spot it before it quietly takes their vision. That responsibility is enormous, and most independent practices know it. What they don’t always have is a clear, repeatable detection and referral pathway that holds up when the diary is full and the locum hasn’t read the notes.

This post is a practical look at how to build one. Not the textbook version — the version that actually survives a Saturday morning when you’ve got three NHS sight tests stacked, a patient with sudden flashes in the waiting room, and a referral from last month that’s bounced back from HES asking for more information.

Why glaucoma detection is an independent optician’s responsibility — and opportunity

NICE guidance (NG81) on glaucoma puts community optometry squarely in the diagnostic chain. The College of Optometrists’ guidance is similar. Around 2% of UK adults over 40 have primary open-angle glaucoma, and the proportion rises steeply with age. Most of those patients have no symptoms until visual field loss is already significant. By the time they notice it, the damage is permanent.

The reality is that your routine sight test is the screening event for the majority of those patients. You’re not just checking if they need a new prescription. You’re the reason their first signs of optic nerve cupping or borderline IOP get caught at all. Done well, this is a clinical responsibility you can build a reputation on. Done poorly, it’s a clinical risk that grows quietly with every patient you see.

For independent practices, there’s an opportunity inside that responsibility. Patients are increasingly aware that not all sight tests are equal. The practice that can clearly explain how it screens for glaucoma — and what it does when something looks borderline — earns trust the multiples can’t easily replicate. That trust translates into recommendations, retention, and the kind of patient loyalty that keeps your appointment book healthy without you having to chase it.

What “good” glaucoma detection actually looks like in 2026

The minimum standard hasn’t changed much: tonometry, optic nerve assessment, visual fields where indicated. What has changed is the depth of what’s available in community practice and what referring HES departments expect to see in a referral.

A modern, defensible pathway in an independent UK practice usually includes:

  • Goldmann or iCare tonometry for IOP, not just non-contact. Patients with IOPs in the borderline zone (21–24 mmHg) get repeat measurements at a different time of day before any decision is made, because diurnal variation is real.
  • Optic nerve head assessment with stereoscopic dilated fundoscopy or, increasingly, OCT imaging of the RNFL and ganglion cell complex. A photo on file is no longer optional — it’s your baseline for the next visit.
  • Visual field testing using a SITA standard or equivalent threshold strategy when there’s any suspicion. A screening field is not enough on its own when the optic disc looks suspicious.
  • Pachymetry for any patient with borderline pressures, because a thin cornea changes how you interpret IOP.
  • Gonioscopy or anterior chamber assessment — at minimum a Van Herick — to rule out angle closure before instilling dilating drops.

None of this is exotic equipment for an independent practice anymore. The bigger gap, in our experience working with practices on Raven Vision, isn’t the kit — it’s the workflow. The clinical data lives in five different places, the referral letters get written from scratch every time, and nobody can quickly tell you which of last quarter’s referrals were actually accepted.

Building the detection pathway: a step-by-step framework

Here’s a workflow that holds up under real clinical pressure. Adapt it to your practice, but the order matters.

Step 1: Risk-stratify at booking, not at the chair

The minute a patient books in, your front desk should know whether they fall into a higher-risk group. First-degree family history of glaucoma. Age over 60. African or Caribbean heritage. Type 2 diabetes. High myopia. Steroid use. These should be flagged on the booking record, not buried in the notes from three years ago. Why does this matter? Because it changes the test you book. A 65-year-old Black patient with a family history shouldn’t be in a 20-minute slot. They should have a longer appointment with imaging built in from the start.

This is where your practice management system earns its keep. If your PMS can’t surface risk flags at the point of booking — or if the receptionist has to dig through old records to find them — you’re going to miss patients who needed the longer slot.

Step 2: Standardise the in-chair workflow

Every clinician in your practice should run the same sequence on every patient. That doesn’t mean every patient gets the same tests — it means every patient is assessed against the same checklist for whether those tests are needed. Without that, your detection rate depends on which optometrist they see, which is exactly the variability HES departments are now flagging in feedback.

A simple working rule: optic disc assessment on every patient, IOP on every patient over 40, visual fields on indication, OCT on indication or routinely if you’ve made the investment. Document the indication in the record, even when it’s a no.

Step 3: Capture imaging on first visit and store it sensibly

An OCT scan or disc photo is only useful if you can pull it up next time. That sounds obvious, but the number of independent practices we see where the imaging lives on the OCT manufacturer’s proprietary software, separate from the patient record, is surprising. When the patient returns in 12 months, the optometrist needs to compare scans side by side without leaving the consulting room.

If your practice management software doesn’t integrate with your imaging — or at minimum let you attach scans to the patient record as referenceable files — you’re losing the comparative power of OCT, which is the whole point.

Step 4: Use a clear “watch list” workflow for borderlines

Most glaucoma cases don’t get referred on the first visit. They get watched. Borderline IOP, suspicious disc, family history but normal everything else — these patients need to come back in 4 to 6 months for repeat assessment, not be lost to a 12-month recall. A watch-list workflow is a simple but consistently mishandled piece of practice operations.

The fix is mechanical. Tag the patient. Set a 4-month recall. Have the recall message reference the previous concern by name (“Following your appointment in May, your optometrist would like to repeat the pressure check we discussed”). Patients turn up when they understand why.

The referral side: getting it accepted first time

A high proportion of community glaucoma referrals get bounced back by HES departments — sometimes 30% or more, depending on the trust. Almost always for the same handful of reasons. None of them are clinical. They’re about completeness.

To make a referral that gets actioned first time, you need to send:

  • Two IOP readings on different occasions, not just the one from this visit
  • Visual field results — a printout, ideally with the reliability indices visible
  • An OCT or disc photo if you have one
  • Pachymetry if available
  • A clear clinical rationale: not “?glaucoma” but “Suspect open-angle glaucoma based on cup:disc ratio of 0.7 with notch superior, IOP 26/24 on repeat, family history positive”
  • Your contact details and the practice’s GOC number

The single biggest cause of bounced referrals we see is missing repeat IOP. It’s also the one that most independent practices solve poorly — they ask the patient to come back, the patient forgets, and three months later the referral letter is still sitting in a drafts folder. A practice management system with a built-in repeat-test workflow that automatically prompts the recall after the first abnormal result removes that whole failure mode.

What about CUES, MECS, and enhanced glaucoma services?

If your area has a Community Urgent Eyecare Service (CUES) or a glaucoma referral refinement scheme, you should be on it. These schemes exist precisely so that low-risk and borderline cases can be managed in community optometry without clogging up HES. They pay reasonably for the time they take, and they lift your clinical credibility with both patients and local commissioners.

The barrier most independents hit isn’t the clinical work — it’s the admin. The schemes have specific data capture requirements, claim formats, and turnaround targets. Doing this on paper is a slow path to giving up. The practices that make CUES and glaucoma referral refinement work are the ones that have built it into the appointment template in their PMS, with the claim data captured during the consultation and submitted automatically rather than retyped at the end of the week.

The overlooked piece: what you tell the patient

Even if your detection workflow is clinically perfect, it falls apart if patients don’t understand what’s happening. A patient who’s told “we’re going to monitor your pressures” walks out thinking it’s nothing. A patient who’s told “your eye pressure was a little higher than we’d like, and your optic nerves have a bit of a borderline appearance — this can be the very early sign of a condition called glaucoma, which is why I want to see you back in four months to check it again carefully” walks out understanding why they need to come back.

Train every clinician in the practice to use the same clear, plain-English language. Have a one-page patient leaflet ready to print at the end of the appointment. Send a follow-up message the next day summarising what was discussed and confirming the next appointment. The clinical risk of glaucoma being missed isn’t only about what you see in the consulting room — it’s about whether the patient acts on what you find.

Auditing your own pathway: the questions worth asking quarterly

Every quarter, sit down for half an hour with whoever runs your clinical operations and answer these:

  • How many glaucoma referrals did we make this quarter?
  • How many were accepted first time, and how many bounced — and why?
  • How many patients were placed on a watch list, and what proportion came back within the recommended timeframe?
  • Are there any clinicians whose detection rate looks unusually high or low? (Either is worth investigating.)
  • What’s our average age at first referral? If it’s creeping up, we’re catching cases late.

You can’t answer most of these without a PMS that captures the data in a structured way. If yours can’t, you’re flying blind on one of the most important clinical metrics in your practice.

Where Raven Vision fits

We built Raven Vision inside Shaukat’s three independent practices in the UK. Glaucoma detection workflows weren’t a feature we bolted on — they were one of the reasons we built our own system in the first place. The clinical record, imaging attachment, recall workflow, watch-list tagging, and eGOS-compatible referral templates all live in the same place. The receptionist can see the risk flag at booking. The optometrist can pull up last year’s OCT side by side with today’s. The recall for a 4-month repeat goes out automatically with the right wording. The referral letter draws from the structured clinical data so it’s complete the first time.

If your current PMS makes any of this harder than it should be — or if you’re still doing parts of it on paper — it’s worth a conversation. Book a 30-minute demo and we’ll walk you through exactly how the glaucoma pathway looks inside Raven Vision, with the workflows already configured for an independent UK practice. £149 a month, three months free, no lock-in. The product is built around the clinical work you actually do, not around what looks good in a sales deck.

The patients who’ll thank you for catching their glaucoma early aren’t the ones who write reviews. They’re the ones who keep their sight, keep recommending you, and keep coming back for the next twenty years. A clean detection pathway is one of the quietest, most valuable investments an independent practice can make. Worth getting right.

Related Posts